title: What does it mean: appropriate therapy for methicillin-resistant Staphylococcus aureus?
authors.forename: Pierluigi
authors.initials: P
authors.lastname: Viale
authors.forename: Federico
authors.initials: F
authors.lastname: Pea
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D003363:Cost Control; D003428:Cross Infection / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007262:Infusions, Intravenous; D007362:Intensive Care Units / Q000191:economics; D007902:Length of Stay / Q000191:economics; D016106:Methicillin Resistance; D011023:Pneumonia, Staphylococcal / Q000097:blood / Q000188:drug therapy*; D012189:Retrospective Studies; D013211:Staphylococcus aureus / Q000187:drug effects*; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D012122:Ventilators, Mechanical / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin